Morten Bøttcher

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

H. Huikuri, H. Suryapranata, A. Bagai, 2024, European heart journal. Cardiovascular pharmacotherapy.

Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

John E. Poremba, H. Randeva, P. Borne, 2024, The Lancet.

Personalized Intervention Based on Early Detection of Atherosclerosis: JACC State-of-the-Art Review.

B. Nordestgaard, J. Lindholt, A. Johri, 2024, Journal of the American College of Cardiology.